Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

McCarthy, Kevin R., Rennick, Linda J., Nambulli, Sham, Robinson-McCarthy, Lindsey R., Bain, William G., Haidar, Ghady, Duprex, W. Paul·2021·Science

Cited by (538)

Items 501–538 of 538

  1. Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core
    Pantelis Poumbourios, Christine Langer, Irene Boo, Tasnim Zakir, Anouschka Akerman, Vanessa Milogiannakis, Anupriya Aggarwal, Stuart Grant Turville, Heidi E. Drummer · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Is the Stalk of the SARS-CoV-2 Spike Protein Druggable?
    Ludovico Pipitò, Christopher Arthur Reynolds, Giuseppe Deganutti · 2022 · Viruses
  3. The SARS-CoV-2 variants around us: A literature review
    D. C. Aloysius, B. H. Siswati · 2023 · Malaysian Journal of Microbiology
  4. Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID
    Maria Grazia Cusi, Anna Maria Di Giacomo, Gabriele Anichini, Gianni Gori Savellini, Chiara Terrosi, Claudia Gandolfo, Michele Maio · 2023 · Viruses
  5. Spike glycoprotein of coronavirus of animals and sars-Cov-2
    Bramhadev Pattnaik, Suresh Puttahonnappa Kuralayanapalya, Chandan Shivamallu, Shiva Prasad Kollur, Mahendra Pal Yadav, Siju Susan Jacob, Awadh Bihari Pandey, Kirankere Ananthapadmanabha Shyamsundar, Sharanagouda Shiddanagouda Patil · 2022 · Indian Journal of Comparative Microbiology Immunology and Infectious Diseases
  6. SARS-CoV-2: Structure, Pathogenesis, and Diagnosis
    Aarthi Goverdhan · 2023 · Elsevier eBooks
  7. Lessons that can be learned from the SARS-CoV-2 pandemic and their impact on the prophylaxis and treatment development for neglected tropical arboviruses
    Danilo Rosa Nunes, Danilo Bancalero Mendonça Lucchi, Robert Andreata‐Santos, Luiz Mário Janini, Carla Torres Braconi · 2023 · Frontiers in Drug Discovery
  8. Cryo-EM reveals variation in structural motifs within animal SARS-related coronavirus spike proteins
    Mihnea Bostina, Francesca R. Hills, Alice-Roza Eruera, Fátima Jorge, Richard A. Easingwood, James Hodgkinson‐Bean, Simon H. J. Brown, James C. Bouwer, Laura N. Burga · 2023 · Research Square
  9. Tracking SARS-CoV-2 variants in Kurdistan Region of Iraq.
    Pyman Mohamed Mohamedsalih, Karzan Jalal Salih, Banaz Omar Kareem, Dana Khdr Sabir · 2023 · ZANCO Journal of Pure and Applied Sciences
  10. Notable variants of SARS COV 2 Virus - A Mini-Review
    Ebidor Ufoumanefe Lawani-Luwaji, Tolulope Alade, John B.U. · 2023 · African Journal of Biology and Medical Research
  11. The Covid-19 and TB Syndemic: Differences and Similarities
    Stefan H. E. Kaufmann, Alan Sher, Alex Sigal, Birgit Sawitzki · 2023 · Frontiers research topics
  12. CNN-Based Detection of SARS-CoV-2 Variants Using Spike Protein Hydrophobicity
    Mohammad Jamhuri, Mohammad Isa Irawan, Imam Mukhlash, Ni Nyoman Tri Puspaningsih · 2023 · International Conference on Advanced Engineering and Technologies (ICONNIC)
  13. A Comparative Analysis of Innate Immune Responses and the Structural Characterization of Spike from SARS-CoV-2 Gamma Variants and Subvariants
    Aline Miranda Scovino, Elizabeth Chen Dahab, Israel Diniz-Lima, Etiele de Senna Silveira, Shana Priscila Coutinho Barroso, Karina Martins-Cardoso, Dirlei Nico, Gustavo José Makhoul, Elias Barbosa da Silva-Júnior, Célio Geraldo Freire-de-Lima et al. · 2024 · Microorganisms
  14. Unveiling Inter- and Intra-Patient Sequence Variability with a Multi-Sample Coronavirus Target Enrichment Approach
    Sara Lado, Jakob Thannesberger, Kathrin Spettel, Jurica Arapović, Bibiana I. Ferreira, Marialuisa Lavitrano, Christoph Steininger · 2024 · Viruses
  15. Differential epitope prediction across diverse circulating variants of SARS-COV-2 in Brazil
    Vanessa de Melo Cavalcanti-Dantas, Brenda Fernandes, Pedro Henrique Lopes Ferreira Dantas, Glaucielle Ramalho Uchoa, Andrei Félix Mendes, Waldecir Oliveira de Araújo Júnior, Lúcio Roberto Cançado Castellano, Ana Isabel Vieira Fernandes, Luíz Ricardo Goulart, Renato Antônio dos Santos Oliveira et al. · 2024 · Computational Biology and Chemistry
  16. SARS-CoV-2 spike protein in infectivity
    Alaa Muayad Altaie, Rania Hamdy, Mohamed Ibrahim Husseiny, Sameh S. M. Soliman · 2025 · Elsevier eBooks
  17. Differential Severity of Sars-Cov-2 Variant Infections in Children and Adults with Covid-19
    Charles Y. Chiu, Noah Brazer, Venice Servellita, Chengshi Jin, Abiodun Foresythe, Miriam Oseguera, Jenny Nguyen, Nanami Sumimoto, Hee Jae Huh, Andries Feder et al. · 2025 · SSRN Electronic Journal
  18. A Novel Antiviral Therapeutic Platform: Anchoring IFN-β to the Surface of Infectious Virions Equips Interferon-Evasive Virions with Potent Antiviral Activity
    H. Jabbour, Alexander G. Bastian, Kayla B. DeOca, Mark D. Mannie · 2025 · Viruses
  19. The structure-based approaches to computing viral fitness
    Rukmankesh Mehra, Shivani Thakur · 2025 · Advances in protein chemistry and structural biology
  20. A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformation
    Huihui Mou, Bo Gao, Gang Ye, Lizhou Zhang, Divyasha Saxena, Fan Bu, Jyoti Vishwakarma, Shuo Zhou, Claudia Ruiz Bayona, Li Lin et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Additional file 1 of Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron
    Simon Schröder, Richter, Anja, Veith, Talitha, Jackson Emanuel, Luca Gudermann, Kirstin Friedmann, Lara Maria Jeworowski, Barbara Mühlemann, Terry C. Jones, Marcel A. Müller et al. · 2024 · Figshare
  22. Additional file 2 of Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
    Shuchen Feng, Gail Reid, Nina M. Clark, Harrington, Amanda, Susan L. Uprichard, Susan C. Baker · 2024 · Figshare
  23. Additional file 1 of Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
    Shuchen Feng, Gail Reid, Nina M. Clark, Harrington, Amanda, Susan L. Uprichard, Susan C. Baker · 2024 · Figshare
  24. Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
    Deepika Jaiswal, Clara G. Altomare, Daniel C. Adelsberg, Iden A. Sapse, Florian Krammer, Viviana R. Simon, Ali H. Ellebedy, Goran Bajic · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Analyse du cycle du SARS-CoV-2 en modèle cellulaire par microscopie électronique à transmission
    Sébastien Eymieux · 2023 · theses.fr (ABES)
  26. The role of O-GlcNAcylation in the pathophysiology of Systemic Lupus Erythematosus
    Gaël Galli · 2022 · theses.fr (ABES)
  27. Caractérisation de la diversité génétique de SARS-CoV-2 dans des échantillons cliniques
    Wahiba Bader · 2022 · theses.fr (ABES)
  28. Modeling and Standard Binding Free Energy Calculations of Complex Biological Objects
    Marharyta Blazhynska · 2023 · theses.fr (ABES)
  29. The mechanisms and consequences of SARS-CoV-2 induced cell-to-cell fusion
    William Bolland · 2024 · theses.fr (ABES)
  30. Combined Effects of Severe Immunocompromise and Prolonged Virus Shedding on Within-Host SARS-CoV-2 Evolution in COVID-19
    Yuichiro Hirata, Kenichiro Takahashi, Noriko Iwamoto, Yong Dam Jeong, Shô Miyamoto, Junna Kawasaki, Montie T. Harrison, Sohtaro Mine, Shun Iida, Shinji Saito et al. · 2026 · medRxiv
  31. Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
    Deepika Jaiswal, Clara G. Altomare, Daniel C. Adelsberg, Iden A. Sapse, Florian Krammer, Viviana R. Simon, Ali H. Ellebedy, Goran Bajic · 2026 · eLife
  32. Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
    Deepika Jaiswal, Clara G. Altomare, Daniel C. Adelsberg, Iden A. Sapse, Florian Krammer, Viviana R. Simon, Ali H. Ellebedy, Goran Bajic · 2026 · eLife
  33. KmerSignificance Score: A discriminative and biologically-informed framework for viral k-mer prioritization
    Dylan Lebatteux, F. Corso, Hugo Soudeyns, Isabelle Boucoiran, S. Gantt, A. Diallo · 2026 · bioRxiv
  34. Evolution of SARS-CoV-2 caused infection in farmed minks: continuous surveillance of an 11-month outbreak at the largest Latvian mink farm
    Ņikita Zrelovs, Edvīns Oļševskis, Jurijs Perevoščikovs, Ivars Silamiķelis, Alise Jakovele, Kristīne Lamberga, Aivars Bērziņš, Monta Brīvība, Jānis Kloviņš · 2026 · Virus Evolution
  35. Recurrent recombination and insertion–deletion events shape the genome-wide evolutionary history of the Coronaviridae family
    Luis Daniel González-Vázquez, David Ferreiro, Filipe Pereira, Miguel Arenas · 2026 · Research Square
  36. Camelid VHHs as a Versatile Platform for Combating Viral Infections
    Mohammed Mufrrih, Thamir A. Alandijany · 2026 · Pharmaceuticals
  37. Multi-Parameter Genomic Evolution of SARS-CoV-2 Across Ten US States During the Vaccination Era, 2020–2025
    Som V. Thomas, Jing Chen, Dong Qian, Paul W. Spearman, Donglu Shi · 2026 · Bioengineering
  38. KmerSignificance score: A discriminative and biologically informed framework for viral k-mer prioritization
    Dylan Lebatteux, Florian Corso, Hugo Soudeyns, Isabelle Boucoiran, Soren M. Gantt, Abdoulaye Baniré Diallo · 2026 · PLoS Computational Biology